文献速递MDS 与骨髓增殖性肿瘤造血干细胞移植与细胞治疗

维生素D受体介导的巨噬细胞分化偏倚引发骨髓纤维化及后续骨硬化

Vitamin D receptor-mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis.
PubMed 文献 · Blood · 2019-02-04

该研究在新型小鼠骨髓纤维化模型中揭示,供体来源F4/80+巨噬细胞与受体来源α-平滑肌肌动蛋白阳性肌成纤维细胞共同构成纤维化组织,维生素D受体信号偏倚巨噬细胞分化;干预维生素D受体信号或清除巨噬细胞可预防该模型及JAK2V617F驱动小鼠骨髓增殖性肿瘤的骨髓纤维化。

要点

  • 骨髓纤维化依赖维生素D受体信号偏倚分化的巨噬细胞。
  • 低维生素D饮食、供体细胞维生素D受体缺陷或巨噬细胞清除可预防模型骨髓纤维化。
  • 上述干预也改善JAK2V617F驱动小鼠骨髓增殖性肿瘤的骨髓纤维化。

核心结论

  • 维生素D受体和巨噬细胞可能是伴骨髓纤维化骨髓增殖性肿瘤的新治疗靶点。

研究设计与样本

  • 研究将VDR+/+造血干/祖细胞移植入VDR-/-小鼠建立新型骨髓纤维化模型,并在JAK2V617F驱动的小鼠骨髓增殖性肿瘤中验证干预效果。

主要发现

  • 在新型模型中,供体来源F4/80+巨噬细胞与受体来源α-平滑肌肌动蛋白阳性肌成纤维细胞共同增殖,二者以难以区分的梭形形态构成纤维化组织。
  • 低维生素D饮食、供体细胞VDR缺陷以及巨噬细胞清除均预防该模型中的骨髓纤维化。
  • 这些干预也改善JAK2V617F驱动小鼠骨髓增殖性肿瘤的骨髓纤维化,可能以转化生长因子-β1或巨核细胞非依赖的方式。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myelofibrosis in myeloproliferative neoplasms (MPNs) with mutations such as JAK2V617F is an unfavorable sign for uncontrollable disease progression in the clinic and is complicated with osteosclerosis whose pathogenesis is largely unknown. Because several studies have revealed that macrophages are an indispensable supporter for bone-forming osteoblasts, we speculated that macrophages might play a significant role in the proliferation of collagen-producing myofibroblasts in marrow fibrotic tissues. Here, we show that myelofibrosis critically depends on macrophages whose differentiation is skewed by vitamin D receptor (VDR) signaling. In our novel myelofibrosis model established by transplantation of VDR+/+ hematopoietic stem/progenitor cells into VDR-/- mice, donor-derived F4/80+ macrophages proliferated together with recipient-derived α-smooth muscle actin-positive myofibroblasts, both of which comprised fibrotic tissues with an indistinguishable spindle-shaped morphology. Interfering VDR signals, such as low vitamin D diet and VDR deficiency in donor cells as well as macrophage depletion prevented myelofibrosis in this model. These interventions also ameliorated myelofibrosis in JAK2V617F-driven murine MPNs likely in a transforming growth factor-β1- or megakaryocyte-independent manner. These results suggest that VDR and macrophages may be novel therapeutic targets for MPNs with myelofibrosis.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Wakahashi K, Minagawa K, Kawano Y, et al. Vitamin D receptor-mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis. Blood. 2019. PMID: 30718230. doi:10.1182/blood-2018-09-876615

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。